ALFA Finder| Revenue growth | 77% YoY consolidated growth in FY26. |
|---|---|
| Margins | Consolidated EBITDA margin improved from 23% to 24% in FY26. |
| Demand visibility | Strong across Pharma, Food, and Automotive testing segments. |
| Management confidence | High; aiming to be leading global lab by 2031-32. |
Growth
FY26 Consolidated Revenue grew 77% YoY to ₹124.5 Cr; PAT surged 90% YoY to ₹14.6 Cr.
Outlook
FY27 guidance: 35-40% revenue growth, 25-26% EBITDA margins. Plans ₹63 Cr capex and new lab acquisitions.
Risks
Expansion into new regions and sectors may face competition and regulatory compliance hurdles across global markets.
Earnings Call filed with BSE, BSE: 544091. Summary written with AI assistance from the document.
Qualitek Labs Ltd: key numbers
- Share price
- ₹541.00
- Market cap
- ₹539.9 Cr
- Revenue (annual)
- ₹124.5 Cr
- Net profit (annual)
- ₹13.62 Cr
- P/E (TTM)
- 39.6×Sector 46.8×
- Promoter holding
- 56.46%
- FII holding
- 1.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Qualitek Labs Ltd
All →Qualitek Labs Board Meeting Date
Qualitek Labs has given notice of a board meeting on 13 November 2026 to consider half-year unaudited results, an MoA alteration and convening an EGM. The trading window closes from 1 October 2026.
Qualitek Labs Management Change
Qualitek Labs' Independent Director Ajay Agarwal resigned effective October 29, 2026, citing personal reasons. He was not on any board committee, so no reconstitution is required.
Qualitek Labs Bags New Order from Bio-Resources Development Centre, Government of Meghalaya
Qualitek Labs' subsidiary Interstellar Testing Centre received a work order from BRDC, Government of Meghalaya for laboratory setup and accreditation. Value is undisclosed citing commercial confidentiality.
- From
- Bio-Resources Development Centre (BRDC), Government of Meghalaya
Qualitek Labs Annual General Meeting
Qualitek Labs issued a corrigendum to its EGM notice scheduled for October 16, 2026. The amendment clarifies shareholding pattern disclosures related to the proposed preferential allotment.
Qualitek Labs Other Announcement
Qualitek Labs Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations for the period ended September 30, 2026.
Qualitek Labs Annual General Meeting
Qualitek Labs Limited held its 8th Annual General Meeting on September 25, 2026. Shareholders approved financial statements, re-appointment of the MD, and material related party transactions.